Zepbound (tirzepatide): FDA approval covers both obesity and type 2 diabetes
MOUNJARO delays gastric emptying and thereby has the potential to impact the absorption of concomitantly administered oral medications [see Drug Interactions (7.2)]
KPV Preclinical Only (Rodent Colitis Dominates) KPVs strongest preclinical signal is in rodent colitis models (DSS-induced, TNBS-induced), where KPV reduces inflammation, normalizes epithelial barrier markers, and lowers cytokine load
This antimicrobial agent prevents bacterial growth in the reconstituted solution, extending its usable life to 2 to 4 weeks when properly refrigerated
Yes, figures containing the L-cell (releasing GLP-1, schematic) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG